Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G.W. Verhaak, Katherine A. Hoadley, Elizabeth Purdom et al. · Cancer Cell · 2010
The Cancer Genome Atlas Network recently cataloged recurrent genomic abnormalities in glioblastoma multiforme (GBM). We describe a robust gene expression-based molecular classification of GBM into Proneural, Neural, Classical, and Mesenchymal subtypes and integrate multidimensional genomic data to establish patterns of somatic mutations and DNA copy number. Aberrations and gene expression of EGFR, NF1, and PDGFRA/IDH1 each define the Classical, Mesenchymal, and Proneural subtypes, respectively. Gene signatures of normal brain cell types show a strong relationship between subtypes and different neural lineages. Additionally, response to aggressive therapy differs by subtype, with the greatest benefit in the Classical subtype and no benefit in the Proneural subtype. We provide a framework that unifies transcriptomic and genomic dimensions for GBM molecular stratification with important implications for future studies.
Cited by 7,553 works. doi:10.1016/j.ccr.2009.12.020 Open-access PDF
Authors
- Roel G.W. Verhaak
- Katherine A. Hoadley
- Elizabeth Purdom
- Victoria Wang
- Yuan Qi
- Matthew D. Wilkerson
- C. Ryan Miller
- Li Ding
- Todd R. Golub
- Jill P. Mesirov
- Gabriele Alexe
- Michael S. Lawrence
- Michael O'Kelly
- Pablo Tamayo
- Barbara A. Weir
- Stacey L. Gabriel
- Wendy Winckler
- Supriya Gupta
- Lakshmi R. Jakkula
- Heidi S. Feiler
References
- In silico prediction of protein-protein interactions in human macrophages
- Significance analysis of microarrays applied to the ionizing radiation response
- Silhouettes: A graphical aid to the interpretation and validation of cluster analysis
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- DAVID: Database for Annotation, Visualization, and Integrated Discovery
- MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
- Summaries of Affymetrix GeneChip probe level data
- Epithelial–mesenchymal transitions in tumour progression
- IDH1 and IDH2 Mutations in Gliomas
- Circular binary segmentation for the analysis of array-based DNA copy number data